Improved method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof

Details for Australian Patent Application No. 2010332988 (hide)

Owner Helmholtz-Zentrum fur Infektionsforschung GmbH Medizinische Hochschule Hannover Gottfried Wilhelm Leibniz Universitat

Inventors Kalesse, Markus; Eggert, Ulrike

Agent Pizzeys

Pub. Number AU-A-2010332988

PCT Pub. Number WO2011/073173

Priority 61/286,097 14.12.09 US

Filing date 14 December 2010

Wipo publication date 23 June 2011

International Classifications

C07B 53/00 Asymmetric syntheses

C07D 209/20 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 513/08 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/073173 Priority application(s): WO2011/073173

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010333005-Electrical and/or electronic device having a resilient contact element

2010332987-Ethynyl derivatives